Cynthia Reese Caulfield Osborne, MD
NPI 1639111503ActiveIndividual· Internal Medicine, Medical Oncology· Dallas, TX
Internal Medicine, Medical Oncology (MD) in Dallas, Texas, trained at University of Texas Medical Branch at Galveston (class of 1996). In 2024 Medicare paid $1,821,519 for 595 patients, and Part D covered 1,035 of their prescriptions, 89% of them generic. Eli Lilly and Company was the largest of 7 companies reporting payments in 2025, $2,115 in all, mostly consulting fees.
Overview
| NPI | 1639111503 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jun 12, 2006 |
| Last updated in NPPES | Oct 26, 2011 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Medical Oncology Primary | 207RX0202X | K7854 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 595 |
|---|---|
| Services billed | 93,386 across 175 procedure codes |
| Paid by Medicare | $1,821,519 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,035 · 1,938 30-day fills |
|---|---|
| Patients | 174 |
| Total drug cost | $1,177,860 |
| Generic share | 89% of claims |
Education and affiliations
| Medical school | University of Texas Medical Branch at Galveston |
|---|---|
| Graduation year | 1996 |
| Medicare specialty | Medical Oncology |
| Secondary specialties | Internal Medicine |
| Telehealth | Offers telehealth |
Medical group
- Texas Oncology PAPlano, TX · 1,014 clinicians
Hospital affiliations
Industry payments (Open Payments)
- 2025$2,115 · 15 payments from 7 companies
- 2024$3,956 · 23 payments from 8 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Eli Lilly and Company | $1,250 | 1 |
| Novartis Pharmaceuticals Corporation | $627.04 | 7 |
| Puma Biotechnology, Inc. | $133.74 | 1 |
| Astrazeneca Pharmaceuticals LP | $35.89 | 2 |
| Tempus Ai, Inc | $29.53 | 2 |
What the 2025 payments were for
- Consulting Fee$1,250 · 1 payment
- Long term medical supply or device loan$598.20 · 6 payments
- Food and Beverage$266.75 · 8 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other medical oncologists in Dallas
- 1013009422
- 1013302645
- 1033358288
- 1083858443
- 1093936809
- 1114136173
- 1134161243
- 1144267766
- 1164460002
- 1164656435
- 1194767061
- 1215348297
All 75 medical oncologists in Dallas · All medical oncologists in Texas